CoChat

The antinociceptive effects of intraplantar injections of 2‐arachidonoyl glycerol are mediated by cannabinoid CB2receptors

Open access
Guindon, J, Desroches, J, Beaulieu, P · 2007 · British Journal of Pharmacology
Cited by 100

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Background and purpose: 2‐arachidonoyl glycerol (2‐AG) is an endogenous cannabinoid with central antinociceptive properties. Its degradation is catalysed by monoacylglycerol lipase (MGL) whose activity is inhibited by URB602, a new synthetic compound. The peripheral antinociceptive effects of 2‐AG and URB602 in an inflammatory model of pain are not yet determined. We have evaluated these effects with and without the cannabinoid CB 1(AM251) and CB 2(AM630) receptor antagonists. Experimental approach: Inflammation was induced in rat hind paws by intraplantar injection of formalin. Nociception was assessed behaviourally over the next 60 min, in 19 experimental groups: (1) control; (2‐6) 2‐AG (0.01‐100 μg); (7) AM251 (80 μg); (8) AM251+2‐AG (10 μg); (9) AM630 (25 μg); (10) AM630+2‐AG (10 μg); (11‐16) URB602 (0.1‐500 μg); (17) 2‐AG+URB602 (ED 50); (18) AM251+URB602 (ED 50); (19) AM630+URB602 (ED 50). Drugs were injected s.c. in the dorsal surface of the hind paw (50 μl), 15 min before formalin injection into the same paw. Key results: 2‐AG and URB602 produced dose‐dependent antinociceptive effects for the late phases of the formalin test with ED 50 of 0.65±0.455 μg and 68±14.3 μg, respectively. Their combination at ED 50 doses produced an additive antinociceptive effect. These effects were inhibited by AM630 but not by AM251 for 2‐AG and by the two cannabinoid antagonists for URB602. Conclusions and implications: Locally injected 2‐AG and URB602 decreased pain behaviour in a dose‐dependent manner in an inflammatory model of pain. The antinociceptive effect of 2‐AG was mediated by the CB 2 receptor. British Journal of Pharmacology(2007)150, 693–701. doi:10.1038/sj.bjp.0706990

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0706990

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 100

Metadata

Authors
Guindon, J., Desroches, J., & Beaulieu, P.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2007-03
Volume
150
Issue
6
Pages
693-701
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2069913986
Cited by
100
References
11
FWCI
6.42
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The antinociceptive effects of intraplantar injections of 2‐arachidonoyl glycerol are mediated by cannabinoid CB2receptors. https://app.cochat.ai/papers/10.1038/sj.bjp.0706990
The paper
Guindon, J., Desroches, J., & Beaulieu, P. (2007). The antinociceptive effects of intraplantar injections of 2‐arachidonoyl glycerol are mediated by cannabinoid CB2receptors. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0706990

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.